• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

终末期肝病模型(MELD)评分对酒精性肝炎患者预后的预测评估

Assessment of the Model for End-stage Liver Disease (MELD) Score in Predicting Prognosis of Patients with Alcoholic Hepatitis.

作者信息

Goyal Sundeep K, Dixit Vinod K, Jain Ashok K, Mohapatra Pradeep K, Ghosh Jayant K

机构信息

Department of Gastroenterology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh 221005, India.

出版信息

J Clin Exp Hepatol. 2014 Mar;4(1):19-24. doi: 10.1016/j.jceh.2014.02.006. Epub 2014 Feb 27.

DOI:10.1016/j.jceh.2014.02.006
PMID:25755531
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4017178/
Abstract

BACKGROUND

Traditionally, Maddrey discriminant function (DF) score has been used for stratifying the prognosis of alcoholic hepatitis. Recently, the Model for end-stage liver disease (MELD) score has been applied to alcoholic hepatitis and some investigators consider MELD score as a better prognostic indicator. Another new prognostic approach, Lille model has been also suggested to accurately identify patients at high risk of death. Therefore, this prospective study was aimed to compare MELD, DF, Child-Turcotte-Pugh (CTP) scores and Lille model for predicting the short-term mortality in Indian patients with alcoholic hepatitis.

METHODS

We calculated the DF, CTP, MELD and Lille scores in patients hospitalized with alcoholic hepatitis & evaluated if the scores predicted in-hospital mortality.

RESULTS

A total of 104 patients were enrolled and thirty-two (30.7%) patients died during the hospitalization (2-30 days). Admission DF score (OR 1.1, P < 0.04), CTP (OR 2, P < 0.05) MELD score (OR 2.2, P < 0.005) and first week MELD score (OR 1.1, P < 0.05) were independently associated with in-hospital mortality. The area under the receiver-operating curve (AUROC) for the admission and day 7 MELD score was significantly higher than CTP score and was comparable to DF score and Lille model (AUC & 95% CI: 0.97 [0.95-1.0], 0.99 [0.99-1.0], 0.91 [0.83-0.91] and 0.92 [0.86-0.98] for MELD at admission & day 7, admission DF and Lille model, respectively). The MELD score >14 at admission and >12 at day 7 had high sensitivity and specificity in predicting short-term mortality (96%, 89% and 95%, 98% respectively). The cutoff of 0.45 for the Lille model was able to identify 79% of the observed deaths, whereas DF score ≥32 for DF were able to identify 85%.

CONCLUSION

MELD score, as a predictive model for assessment of short-term mortality in alcoholic hepatitis is better than CTP and comparable to DF and Lille model.

摘要

背景

传统上,马德雷判别函数(DF)评分一直用于对酒精性肝炎的预后进行分层。最近,终末期肝病模型(MELD)评分已应用于酒精性肝炎,一些研究者认为MELD评分是更好的预后指标。另一种新的预后评估方法,里尔模型也被提出用于准确识别高死亡风险患者。因此,本前瞻性研究旨在比较MELD、DF、Child-Turcotte-Pugh(CTP)评分和里尔模型对印度酒精性肝炎患者短期死亡率的预测情况。

方法

我们计算了因酒精性肝炎住院患者的DF、CTP、MELD和里尔评分,并评估这些评分是否能预测住院死亡率。

结果

共纳入104例患者,32例(30.7%)患者在住院期间(2 - 30天)死亡。入院时DF评分(比值比1.1,P < 0.04)、CTP评分(比值比2,P < 0.05)、MELD评分(比值比2.2,P < 0.005)以及第1周MELD评分(比值比1.1,P < 0.05)均与住院死亡率独立相关。入院时及第7天MELD评分的受试者工作特征曲线下面积(AUROC)显著高于CTP评分,与DF评分和里尔模型相当(入院时及第7天MELD评分、入院DF评分和里尔模型的AUC及95%可信区间分别为:0.97 [0.95 - 1.0]、0.99 [0.99 - 1.0]、0.91 [0.83 - 0.91]和0.92 [0.86 - 0.98])。入院时MELD评分>14及第7天>12对短期死亡率的预测具有较高的敏感性和特异性(分别为96%、89%和95%、98%)。里尔模型的截断值为0.45时能够识别79%的观察到的死亡病例,而DF评分≥32时能够识别85%。

结论

MELD评分作为评估酒精性肝炎短期死亡率的预测模型,优于CTP评分,与DF评分和里尔模型相当。

相似文献

1
Assessment of the Model for End-stage Liver Disease (MELD) Score in Predicting Prognosis of Patients with Alcoholic Hepatitis.终末期肝病模型(MELD)评分对酒精性肝炎患者预后的预测评估
J Clin Exp Hepatol. 2014 Mar;4(1):19-24. doi: 10.1016/j.jceh.2014.02.006. Epub 2014 Feb 27.
2
[Comparison of model for end-stage liver disease score with discriminant function and child-Turcotte-Pugh scores for predicting short-term mortality in Korean patients with alcoholic hepatitis].[终末期肝病模型评分与判别函数及Child-Turcotte-Pugh评分在预测韩国酒精性肝炎患者短期死亡率中的比较]
Korean J Gastroenterol. 2007 Feb;49(2):93-9.
3
Predicting Mortality Across a Broad Spectrum of Liver Disease-An Assessment of Model for End-Stage Liver Disease (MELD), Child-Turcotte-Pugh (CTP), and Creatinine-Modified CTP Scores.预测广泛肝病患者的死亡率——对终末期肝病模型(MELD)、Child-Turcotte-Pugh(CTP)评分以及肌酐修正CTP评分的评估
J Clin Exp Hepatol. 2011 Dec;1(3):161-8. doi: 10.1016/S0973-6883(11)60233-8. Epub 2012 Jan 2.
4
MELD score is a better prognostic model than Child-Turcotte-Pugh score or Discriminant Function score in patients with alcoholic hepatitis.对于酒精性肝炎患者,终末期肝病模型(MELD)评分是比Child-Turcotte-Pugh评分或判别函数评分更好的预后模型。
J Hepatol. 2005 May;42(5):700-6. doi: 10.1016/j.jhep.2004.12.022.
5
Application of prognostic scores in the STOPAH trial: Discriminant function is no longer the optimal scoring system in alcoholic hepatitis.预后评分在 STOPAH 试验中的应用:判别函数不再是酒精性肝炎的最佳评分系统。
J Hepatol. 2018 Mar;68(3):511-518. doi: 10.1016/j.jhep.2017.11.017. Epub 2017 Nov 21.
6
APACHE II score is superior to SOFA, CTP and MELD in predicting the short-term mortality in patients with acute-on-chronic liver failure (ACLF).APACHE II 评分优于 SOFA、CTP 和 MELD,可预测慢加急性肝衰竭(ACLF)患者的短期死亡率。
J Dig Dis. 2013 Sep;14(9):484-90. doi: 10.1111/1751-2980.12074.
7
Combining Data From Liver Disease Scoring Systems Better Predicts Outcomes of Patients With Alcoholic Hepatitis.联合应用肝脏疾病评分系统的数据可更好地预测酒精性肝炎患者的预后。
Gastroenterology. 2015 Aug;149(2):398-406.e8; quiz e16-7. doi: 10.1053/j.gastro.2015.04.044. Epub 2015 Apr 29.
8
The Impact of Metabolic Syndrome on the Prognosis of High-Risk Alcoholic Hepatitis Patients: Redefining Alcoholic Hepatitis.代谢综合征对高危酒精性肝炎患者预后的影响:重新定义酒精性肝炎
Gastroenterology Res. 2023 Feb;16(1):25-36. doi: 10.14740/gr1556. Epub 2023 Feb 28.
9
Evaluation of MELD score and Maddrey discriminant function for mortality prediction in patients with alcoholic hepatitis.评估终末期肝病模型(MELD)评分和马德雷判别函数对酒精性肝炎患者死亡率的预测价值。
Hepatogastroenterology. 2013 Jul-Aug;60(125):1089-94. doi: 10.5754/hge11969.
10
[Comparative study of the MELD-Na and Child-Turcotte-Pugh scores as short-term prognostic indicators of acute-on-chronic hepatitis B liver failure].[MELD-Na评分与Child-Turcotte-Pugh评分作为慢性乙型肝炎急性肝衰竭短期预后指标的比较研究]
Zhonghua Gan Zang Bing Za Zhi. 2014 Nov;22(11):801-5. doi: 10.3760/cma.j.issn.1007-3418.2014.11.001.

引用本文的文献

1
Prognostic and diagnostic scoring models in acute alcohol-associated hepatitis: A review comparing the performance of different scoring systems.急性酒精相关性肝炎的预后和诊断评分模型:比较不同评分系统性能的综述
World J Hepatol. 2023 Aug 27;15(8):954-963. doi: 10.4254/wjh.v15.i8.954.
2
Global prevalence, incidence, and outcomes of alcohol related liver diseases: a systematic review and meta-analysis.全球酒精相关性肝病的患病率、发病率和结局:系统评价和荟萃分析。
BMC Public Health. 2023 May 11;23(1):859. doi: 10.1186/s12889-023-15749-x.
3
Incidence and Progression of Alcohol-Associated Liver Disease After Medical Therapy for Alcohol Use Disorder.酒精使用障碍治疗后与酒精相关的肝病的发生率和进展。
JAMA Netw Open. 2022 May 2;5(5):e2213014. doi: 10.1001/jamanetworkopen.2022.13014.
4
Substance use disorder is associated with alcohol-associated liver disease in patients with alcohol use disorder.物质使用障碍与酒精使用障碍患者的酒精性肝病相关。
Gastro Hep Adv. 2022;1(3):403-408. doi: 10.1016/j.gastha.2022.02.004. Epub 2022 Mar 30.
5
Evaluation and Management of Cirrhotic Patients Undergoing Elective Surgery.接受择期手术的肝硬化患者的评估与管理
Curr Gastroenterol Rep. 2019 Jun 15;21(7):32. doi: 10.1007/s11894-019-0700-y.
6
Predictors of 90-day mortality in patients with severe alcoholic hepatitis: Experience with 183 patients at a tertiary care center from India.重症酒精性肝炎患者90天死亡率的预测因素:来自印度一家三级医疗中心183例患者的经验
Indian J Gastroenterol. 2018 Mar;37(2):141-152. doi: 10.1007/s12664-018-0842-0. Epub 2018 Apr 28.
7
Pharmacologic Treatment of Alcoholic Hepatitis: Examining Outcomes Based on Disease Severity Stratification.酒精性肝炎的药物治疗:基于疾病严重程度分层的疗效考察
J Clin Exp Hepatol. 2016 Dec;6(4):275-281. doi: 10.1016/j.jceh.2016.07.003. Epub 2016 Jul 18.
8
Assessment of scoring systems for acute-on-chronic liver failure at predicting short-term mortality in patients with alcoholic hepatitis.评估急性-on-慢性肝衰竭评分系统对酒精性肝炎患者短期死亡率的预测价值。
World J Gastroenterol. 2016 Nov 7;22(41):9205-9213. doi: 10.3748/wjg.v22.i41.9205.

本文引用的文献

1
Early liver transplantation for severe alcoholic hepatitis.早期肝移植治疗严重酒精性肝炎。
N Engl J Med. 2011 Nov 10;365(19):1790-800. doi: 10.1056/NEJMoa1105703.
2
Alcoholic liver disease.酒精性肝病
Hepatology. 2010 Jan;51(1):307-28. doi: 10.1002/hep.23258.
3
Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders.饮酒及酒精使用障碍所致的全球疾病负担、伤害及经济成本。
Lancet. 2009 Jun 27;373(9682):2223-33. doi: 10.1016/S0140-6736(09)60746-7.
4
The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids.里尔模型:用于接受类固醇治疗的重症酒精性肝炎患者治疗策略的新工具。
Hepatology. 2007 Jun;45(6):1348-54. doi: 10.1002/hep.21607.
5
Predicting utility of a model for end stage liver disease in alcoholic liver disease.预测酒精性肝病中终末期肝病模型的效用。
World J Gastroenterol. 2006 Jul 7;12(25):4020-5. doi: 10.3748/wjg.v12.i25.4020.
6
MELD score is a better prognostic model than Child-Turcotte-Pugh score or Discriminant Function score in patients with alcoholic hepatitis.对于酒精性肝炎患者,终末期肝病模型(MELD)评分是比Child-Turcotte-Pugh评分或判别函数评分更好的预后模型。
J Hepatol. 2005 May;42(5):700-6. doi: 10.1016/j.jhep.2004.12.022.
7
MELD accurately predicts mortality in patients with alcoholic hepatitis.终末期肝病模型(MELD)能准确预测酒精性肝炎患者的死亡率。
Hepatology. 2005 Feb;41(2):353-8. doi: 10.1002/hep.20503.
8
Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis (AH): individual data analysis of the last three randomized placebo controlled double blind trials of corticosteroids in severe AH.皮质类固醇可改善重症酒精性肝炎(AH)患者的短期生存率:对皮质类固醇治疗重症AH的最近三项随机安慰剂对照双盲试验的个体数据分析
J Hepatol. 2002 Apr;36(4):480-7. doi: 10.1016/s0168-8278(01)00289-6.
9
Utility of the Mayo End-Stage Liver Disease (MELD) score in assessing prognosis of patients with alcoholic hepatitis.梅奥终末期肝病(MELD)评分在评估酒精性肝炎患者预后中的应用。
BMC Gastroenterol. 2002;2:2. doi: 10.1186/1471-230x-2-2. Epub 2002 Jan 22.
10
A model to predict survival in patients with end-stage liver disease.一种预测终末期肝病患者生存率的模型。
Hepatology. 2001 Feb;33(2):464-70. doi: 10.1053/jhep.2001.22172.